Cimon Medical GmbH

Founding year

2021

Sector

Life Sciences / Medical technology

Description

At Cimon Medical, we have developed a plattform technology for continious and direct blood flow monitoring.

Out first product, NeoDoppler®, is the first device that continously monitors cerebral blood flow in infants, thereby helping to prevent brain damage. Our non-invasive, user-friendly technology can be used during surgeries and in the ward. NeoDoppler® has been CE-marked (2b) since 2023 and is already in use in over 20 hospitals across Europe.